177 related articles for article (PubMed ID: 37547001)
21. Small ring has big potential: insights into extrachromosomal DNA in cancer.
Wang Y; Huang R; Zheng G; Shen J
Cancer Cell Int; 2021 Apr; 21(1):236. PubMed ID: 33902601
[TBL] [Abstract][Full Text] [Related]
22. Extrachromosomal circular DNA in colorectal cancer: biogenesis, function and potential as therapeutic target.
Chen Y; Qiu Q; She J; Yu J
Oncogene; 2023 Mar; 42(13):941-951. PubMed ID: 36859558
[TBL] [Abstract][Full Text] [Related]
23. Circular ecDNA promotes accessible chromatin and high oncogene expression.
Wu S; Turner KM; Nguyen N; Raviram R; Erb M; Santini J; Luebeck J; Rajkumar U; Diao Y; Li B; Zhang W; Jameson N; Corces MR; Granja JM; Chen X; Coruh C; Abnousi A; Houston J; Ye Z; Hu R; Yu M; Kim H; Law JA; Verhaak RGW; Hu M; Furnari FB; Chang HY; Ren B; Bafna V; Mischel PS
Nature; 2019 Nov; 575(7784):699-703. PubMed ID: 31748743
[TBL] [Abstract][Full Text] [Related]
24. Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma.
Chapman OS; Luebeck J; Sridhar S; Wong IT; Dixit D; Wang S; Prasad G; Rajkumar U; Pagadala MS; Larson JD; He BJ; Hung KL; Lange JT; Dehkordi SR; Chandran S; Adam M; Morgan L; Wani S; Tiwari A; Guccione C; Lin Y; Dutta A; Lo YY; Juarez E; Robinson JT; Korshunov A; Michaels JA; Cho YJ; Malicki DM; Coufal NG; Levy ML; Hobbs C; Scheuermann RH; Crawford JR; Pomeroy SL; Rich JN; Zhang X; Chang HY; Dixon JR; Bagchi A; Deshpande AJ; Carter H; Fraenkel E; Mischel PS; Wechsler-Reya RJ; Bafna V; Mesirov JP; Chavez L
Nat Genet; 2023 Dec; 55(12):2189-2199. PubMed ID: 37945900
[TBL] [Abstract][Full Text] [Related]
25. Breaking the vicious circle: Extrachromosomal circular DNA as an emerging player in tumour evolution.
Robert M; Crasta K
Semin Cell Dev Biol; 2022 Mar; 123():140-150. PubMed ID: 34857471
[TBL] [Abstract][Full Text] [Related]
26. Insight on ecDNA-mediated tumorigenesis and drug resistance.
Huang Q; Zhang S; Wang G; Han J
Heliyon; 2024 Mar; 10(6):e27733. PubMed ID: 38545177
[TBL] [Abstract][Full Text] [Related]
27. Progress on the role of extrachromosomal DNA in tumor pathogenesis and evolution.
Xing J; Ning Q; Tang D; Mo Z; Lei X; Tang S
Clin Genet; 2021 Apr; 99(4):503-512. PubMed ID: 33314031
[TBL] [Abstract][Full Text] [Related]
28. Extrachromosomal DNA: An Emerging Hallmark in Human Cancer.
Wu S; Bafna V; Chang HY; Mischel PS
Annu Rev Pathol; 2022 Jan; 17():367-386. PubMed ID: 34752712
[TBL] [Abstract][Full Text] [Related]
29. Pioneering insights of extrachromosomal DNA (ecDNA) generation, action and its implications for cancer therapy.
Li Z; Wang B; Liang H; Han L
Int J Biol Sci; 2022; 18(10):4006-4025. PubMed ID: 35844796
[TBL] [Abstract][Full Text] [Related]
30. Oncogene Convergence in Extrachromosomal DNA Hubs.
Weiser NE; Hung KL; Chang HY
Cancer Discov; 2022 May; 12(5):1195-1198. PubMed ID: 35398879
[TBL] [Abstract][Full Text] [Related]
31. Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity.
Turner KM; Deshpande V; Beyter D; Koga T; Rusert J; Lee C; Li B; Arden K; Ren B; Nathanson DA; Kornblum HI; Taylor MD; Kaushal S; Cavenee WK; Wechsler-Reya R; Furnari FB; Vandenberg SR; Rao PN; Wahl GM; Bafna V; Mischel PS
Nature; 2017 Mar; 543(7643):122-125. PubMed ID: 28178237
[TBL] [Abstract][Full Text] [Related]
32. Impact of ecDNA: A mechanism that directs tumorigenesis in cancer drug Resistance-A review.
Ashique S; Upadhyay A; Garg A; Mishra N; Hussain A; Negi P; Hing GB; Bhatt S; Ali MK; Gowthamarajan K; Singh SK; Gupta G; Chellappan DK; Dua K
Chem Biol Interact; 2022 Aug; 363():110000. PubMed ID: 35671828
[TBL] [Abstract][Full Text] [Related]
33. Extrachromosomal DNA formation enables tumor immune escape potentially through regulating antigen presentation gene expression.
Wu T; Wu C; Zhao X; Wang G; Ning W; Tao Z; Chen F; Liu XS
Sci Rep; 2022 Mar; 12(1):3590. PubMed ID: 35246593
[TBL] [Abstract][Full Text] [Related]
34. MGA-seq: robust identification of extrachromosomal DNA and genetic variants using multiple genetic abnormality sequencing.
Lin D; Zou Y; Li X; Wang J; Xiao Q; Gao X; Lin F; Zhang N; Jiao M; Guo Y; Teng Z; Li S; Wei Y; Zhou F; Yin R; Zhang S; Xing L; Xu W; Wu X; Yang B; Xiao K; Wu C; Tao Y; Yang X; Zhang J; Hu S; Dong S; Li X; Ye S; Hong Z; Pan Y; Yang Y; Sun H; Cao G
Genome Biol; 2023 Oct; 24(1):247. PubMed ID: 37904244
[TBL] [Abstract][Full Text] [Related]
35. Imaging extrachromosomal DNA (ecDNA) in cancer.
Purshouse K; Pollard SM; Bickmore WA
Histochem Cell Biol; 2024 Apr; ():. PubMed ID: 38625562
[TBL] [Abstract][Full Text] [Related]
36. Novel insights into extrachromosomal DNA: redefining the onco-drivers of tumor progression.
Gu X; Yu J; Chai P; Ge S; Fan X
J Exp Clin Cancer Res; 2020 Oct; 39(1):215. PubMed ID: 33046109
[TBL] [Abstract][Full Text] [Related]
37. Revisiting characteristics of oncogenic extrachromosomal DNA as mobile enhancers on neuroblastoma and glioma cancers.
Karami Fath M; Karimfar N; Fazlollahpour Naghibi A; Shafa S; Ghasemi Shiran M; Ataei M; Dehghanzadeh H; Nabi Afjadi M; Ghadiri T; Payandeh Z; Tarhriz V
Cancer Cell Int; 2022 May; 22(1):200. PubMed ID: 35614494
[TBL] [Abstract][Full Text] [Related]
38. The biogenesis and roles of extrachromosomal oncogene involved in carcinogenesis and evolution.
Wei J; Wu C; Meng H; Li M; Niu W; Zhan Y; Jin L; Duan Y; Zeng Z; Xiong W; Li G; Zhou M
Am J Cancer Res; 2020; 10(11):3532-3550. PubMed ID: 33294253
[TBL] [Abstract][Full Text] [Related]
39. Leveraging extrachromosomal DNA to fine-tune trials of targeted therapy for glioblastoma: opportunities and challenges.
Noorani I; Mischel PS; Swanton C
Nat Rev Clin Oncol; 2022 Nov; 19(11):733-743. PubMed ID: 36131011
[TBL] [Abstract][Full Text] [Related]
40. [Amplification of Extrachromosomal Oncogene and Tumorigenesis and Development].
Wang Y; Ye F; Zhang X; Zou R; Wang M; Yu K; Cui S
Zhongguo Fei Ai Za Zhi; 2020 Dec; 23(12):1101-1107. PubMed ID: 33357318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
